메뉴 건너뛰기




Volumn 65, Issue 16, 2009, Pages 3292-3304

Development of two synthetic routes to CE-178,253, a CB1 antagonist for the treatment of obesity

Author keywords

1,3,5 Triazine; CB1 antagonist; Obesity; Pyrazolotriazine; Suzuki coupling; Thiosemicarbazide

Indexed keywords

ANTIOBESITY AGENT; BENZENESULFONIC ACID DERIVATIVE; CANNABINOID 1 RECEPTOR ANTAGONIST; CE 178253; KETONE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; THIOSEMICARBAZIDE DERIVATIVE; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 62049083037     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2008.10.067     Document Type: Article
Times cited : (30)

References (28)
  • 10
    • 62049084798 scopus 로고    scopus 로고
    • U.S. Patent 2,004,157,839, 2004
    • Griffith, D. A. U.S. Patent 2,004,157,839, 2004.
    • Griffith, D.A.1
  • 12
    • 62049083139 scopus 로고    scopus 로고
    • U.S. Patent 2,004,157,838, 2004
    • Griffith, D. A. U.S. Patent 2,004,157,838, 2004.
    • Griffith, D.A.1
  • 14
    • 62049084046 scopus 로고    scopus 로고
    • WO 2005054184
    • Brandt, T. A. WO 2005054184, 2005.
    • (2005)
    • Brandt, T.A.1
  • 15
    • 62049083429 scopus 로고    scopus 로고
    • WO 2006131807
    • Ghosh, A.; Wei, L. WO 2006131807, 2006.
    • (2006)
    • Ghosh, A.1    Wei, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.